This Fund Just Dumped Itron Stock, but Should Long-Term Investors Follow Suit?

Aristotle Capital Boston trimmed its Itron (ITRI) holding in Q3 by 123,119 shares, reducing the position by roughly $18.35 million and leaving 303,560 shares valued at $37.8 million as of Sept. 30 (about 1.95% of its reportable U.S. equity AUM). Itron shares trade around $95.22, down about 15% over the past year, yet the company’s latest quarter showed softer revenue (-5% to $582m) offset by stronger profitability and cash conversion—gross margin expanded 360 bps to 37.7%, adjusted EBITDA rose 10% to $97m, free cash flow nearly doubled to $113m, and backlog sits at $4.3bn. The move appears to be a modest rebalancing or gain-taking within a concentrated portfolio rather than a clear signal of deteriorating fundamentals, and Itron’s improving margins and recurring-revenue backdrop keep it positioned to benefit from long-duration utility grid modernization spending.

Analysis

Aristotle Capital Boston trimmed its Itron (ITRI) stake by 123,119 shares in Q3, a move the filing values as reducing the position by roughly $18.35 million while the estimated transaction value using quarterly average pricing is about $15.7 million; post-trade the fund holds 303,560 shares worth $37.8 million as of September 30, representing about 1.95% of its reportable U.S. equity AUM. Itron shares trade at $95.22 and are down ~15% over the past year, materially underperforming the S&P 500 which is up ~13% in the same period, and the stock experienced a roughly 20% pullback after a prior surge.

Operationally, Itron reported revenue of $582 million (down 5% year-over-year) while gross margin expanded 360 basis points to 37.7%, adjusted EBITDA rose 10% to $97 million, and free cash flow nearly doubled to $113 million; the company also cites a $4.3 billion backlog and growing recurring revenue in its Outcomes segment. The mix of near-term revenue softness from project timing and clear margin and cash-flow improvement suggests improving underlying profitability despite cyclical timing issues, supporting a thesis tied to long-duration utility grid modernization spending.

The fund’s reduction appears consistent with partial gain-taking or rebalancing in a concentrated portfolio rather than an outright loss of conviction, but the trimming is a proximate signal for investors to monitor flows and subsequent 13F updates. Key risks to watch are continued revenue volatility tied to project timing and any erosion in backlog conversion; key positives are margin expansion and materially stronger cash conversion that provide near-term liquidity resilience.

Key Decisions for Investors

• Monitor Itron’s next two quarters for revenue trajectory and whether backlog converts to booked revenue, as sustained conversion would validate the margin and free-cash-flow improvements
• Consider incremental accumulation on meaningful pullbacks if you have a multi-quarter horizon and exposure to utility modernization, but size new positions conservatively given recent revenue softness
• Watch institutional filing activity (further Aristotle or peer trims) and daily flow for signs of sustained selling that could pressure the stock, and use hedges or stop limits if short-term volatility is a concern
• Prioritize metrics over price action: outperformance in adjusted EBITDA and free cash flow should be the primary triggers for adding risk, while deteriorating backlog or margin reversal should prompt reassessment